Pioneering Dry Eye Treatments

Eyedetec Medical ensures a unique continuum of care for dry-eye patients

THE CLINICAL CHALLENGE

A Tsunami of Dry Eye Disease Patients Resulting from Increasing Use of Digital Displays

IMPACT OF DIGITAL INTERFACE ON BLINKING

Natural mechanism, essential for ocular surface health

Reduction from 15 to 5/7 times per minute

eyedetec old woman

DIGITAL EYE STRAIN

Dry eye symptoms and other internal symptoms

Estimated prevalence +50% with digital user

eyedetec man

A recent Gartner poll showed that 48% of employees will likely work remotely at least part of the time after COVID-19 versus 30% before the pandemic.

No Cure and Inadequate Treatments for
Dry Eye Disease (DED) & Meibomian Gland Dysfunction (MGD)

eyedetec eye

Major Impact

on Quality of Life and Quality of Vision

eyedetec negative finance

Growing Financial

Burden $7.8B by 2025*

No Cure at Present Available

1 Clin Ophthalmol. 2/19; 13: 225–232
2 Transparency Market Research, 1/18
3 AARP report, 11/15

Urgent Need for a Scalable & Efficient Treatment Solution

Harris Williams Vision Industry Overview 2019 - USA

Limited growth in Eye Care Professionals (ECPs), while DED prevalence tripled in 7-year period (20% annually)

https://www.reviewofoptometry.com/article/dry-eye-rate-triples-over-sevenyear-period

TARGET MARKET AND POTENTIAL

Key Factors Driving the Dry Eye Disease Market

eyedetec cataract

REFRACTIVE
CATARACT SURGERY

$4B global IOL market

eyedetec lens

CONTACT LENS
INTOLERANCE 38%

$14B global CTL market

eyedete aging

INCREASED INCIDENCE
WITH AGING POPULATION

25% of population >50 y.o.

eyedetec tech

SCREEN TIME &
DECREASED BLINKING

Coming DED tsunami!

The Eye Lipid Mobilizer™ (ELM) Technology Ensures
Effective Continuity of Treatment

Novel, patented technology - Eye Lipid Mobilizer

eyedetec pre treatment
eyedetec treatment film

The ELM ™ - Key Differentiators

Telehealth - Paradigm Shift to Tackle Healthcare Challenges

Why Invest in the Future of Dry Eye care?

Management Team

Barry J Linder, MD, MS President & CEO
Thomas Dunlap Global Business Advisor
Shareef Mahdavi Strategic Marketing
Anselm Leung CFO
James Dippo R&D
John Kang RQ&C
Ronald Linder Operations

Scientific Advisory Board

Daniel Durrie, MD
Randall Fuerst, OD
John Hovanesian, MD
Paul Karpecki, OD
Leslie O'Dell, OD
Laura Periman, MD
John Sheppard, MD
Vance Thompson, MD